Immatics N.V.(IMTX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
IMTX Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Immatics N.V. (IMTX), a Healthcare sector company. IMTX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of IMTX by reported 13-F value include T. Rowe Price Investment Management, RTW INVESTMENTS, SUVRETTA CAPITAL MANAGEMENT, based on the most recent SEC filings. IMTX trades on the Nasdaq exchange and files with the SEC under CIK 1809196. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IMTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Immatics N.V. directly from SEC EDGAR.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProTotal Assets
-19.2% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $562.3M -19.2% | $696.1M +36.5% | $510.0M +25.0% | $407.8M +133.5% | $174.6M -31.4% | $254.6M |
Get alerted when IMTX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Immatics N.V. including:
Top Institutional Holders of IMTX
T. Rowe Price Investment Management, Inc.
$226.6M22,365,046 shRTW INVESTMENTS, LP
$131.1M12,946,176 shSUVRETTA CAPITAL MANAGEMENT, LLC
$113.4M11,190,129 shPERCEPTIVE ADVISORS LLC
$105.2M10,383,456 shBAKER BROS. ADVISORS LP
$96.3M9,508,565 shLEUCADIA NATIONAL CORP
$65.9M6,506,802 shVestal Point Capital, LP
$62.6M6,175,000 shSofinnova Ventures Inc
$37.2M3,669,346 shMORGAN STANLEY
$22.1M2,186,494 shCITADEL ADVISORS LLC
$18.4M1,814,657 sh
| Fund | Value | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | $226.6M | 22,365,046 |
| RTW INVESTMENTS, LP | $131.1M | 12,946,176 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | $113.4M | 11,190,129 |
| PERCEPTIVE ADVISORS LLC | $105.2M | 10,383,456 |
| BAKER BROS. ADVISORS LP | $96.3M | 9,508,565 |
| LEUCADIA NATIONAL CORP | $65.9M | 6,506,802 |
| Vestal Point Capital, LP | $62.6M | 6,175,000 |
| Sofinnova Ventures Inc | $37.2M | 3,669,346 |
| MORGAN STANLEY | $22.1M | 2,186,494 |
| CITADEL ADVISORS LLC | $18.4M | 1,814,657 |
More Healthcare Companies
View all Healthcare →Put IMTX on your watchlist
Track score changes the day Immatics N.V. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IMTX a good stock to buy?
13F Pro's AI-powered analysis of Immatics N.V. (IMTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IMTX are available on the IMTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. IMTX is classified as a small company.
Which hedge funds own IMTX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IMTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Immatics N.V.'s investment landscape.